Kintor Pharma announces first patient dosing of phase-III clinical trial of Pyrilutamide to treat… EP News Bureau Jan 4, 2022 On 24th November, 2021, Kintor Pharma announced that China's National Medical Products Administration (NMPA) greenlighted the…
